HomeBlogHow to Prevent Muscle Loss on Ozempic, Wegovy, and Zepbound
Blog

How to Prevent Muscle Loss on Ozempic, Wegovy, and Zepbound

Jean Santiago
Jean Santiago
Blog · 14 min read
Updated April 19, 2026

A friend of ours hit her goal weight on Wegovy in about seven months. She was thrilled with the number on the scale. What she didn't expect was that she'd feel physically weaker — climbing stairs that used to be nothing, carrying groceries that suddenly felt heavy. Her doctor explained it after the fact: some of what she lost wasn't fat.

Nobody had mentioned that part.

GLP-1 medications are genuinely impressive at producing weight loss. They're less impressive at specifying where that weight comes from. Clinical trial body composition data consistently shows that 25–39% of total weight lost on semaglutide and tirzepatide comes from lean mass — muscle, water, and connective tissue — rather than fat.

That number has real consequences. Muscle loss slows your resting metabolic rate, increases the risk of weight regain when treatment stops, and in older adults specifically can accelerate functional decline. The good news is that this ratio isn't fixed — it responds directly to what you eat and how you train. We've mapped the evidence-based protocol here.

Key Takeaways

  • Body composition data from SURMOUNT-1 shows roughly 25% of weight lost on tirzepatide came from lean mass. Semaglutide data shows a similar pattern, with some analyses reaching 39% in specific populations.
  • Protein at 1.2–2.0g per kilogram of body weight daily is the single most effective dietary intervention for preserving lean mass during GLP-1 therapy.
  • Resistance training 2–3 times per week is the most powerful signal the body receives to hold onto muscle during a caloric deficit — more powerful than any supplement.
  • Creatine monohydrate at 5g daily has direct clinical support for maintaining strength and lean mass during caloric restriction — and it's one of the most studied supplements in existence.
  • Muscle loss compounds the weight regain risk after stopping a GLP-1 — which is one more reason to treat preservation as a priority from day one, not an afterthought.

Why GLP-1s Cause Lean Mass Loss in the First Place

GLP-1 medications don't target fat specifically. They suppress appetite, which reduces overall calorie intake, which puts the body in a deficit. In a deficit, the body draws on stored energy — primarily fat, but also protein from muscle tissue.

The faster and deeper the deficit, the more lean mass tends to get pulled in alongside fat. This is why GLP-1s — which are unusually good at creating large, sustained deficits — show more lean mass loss than slower dietary interventions.

There's a second factor: protein intake drops with appetite. When you're eating 30–40% less food overall, you're typically eating 30–40% less protein. And protein is the direct substrate for muscle repair and synthesis. Cut it, and the muscle-preservation machinery loses its raw material.

The third factor is activity. GLP-1 medications can cause fatigue during dose escalation, and reduced energy levels often translate to less movement. Less movement means weaker anabolic signals to muscle tissue — less reason for the body to hold onto it.

These three factors compound each other. But they're all modifiable.

The Research on Lean Mass Loss — What the Trials Actually Show

25%

Lean mass lost

SURMOUNT-1 Body Composition Substudy

In SURMOUNT-1, tirzepatide produced average body weight reduction of 21.3%, with fat mass falling 33.9% and lean mass falling 10.9%. About 75% of total tissue lost was fat; 25% was lean — the cleanest large-trial body composition data currently available for this drug class.

Read the full study in New England Journal of Medicine, 2023 · Body composition substudy · n=938

The semaglutide picture is similar but has more variation across studies. A 2025 review from the Endocrine Society found that being older, female, or eating less protein was linked to greater lean mass loss on semaglutide — suggesting the 25% figure from tirzepatide data may underestimate what happens in higher-risk subgroups.

Retatrutide's phase 2 body composition data showed roughly 64% fat and 36% lean mass across the total weight lost — a somewhat less favorable ratio, possibly driven by the speed and magnitude of loss at the highest doses. We covered the full retatrutide picture in what retatrutide actually is.

The key takeaway across all three: lean mass loss is a documented, expected feature of GLP-1 therapy — not a rare side effect. Treating it as optional to address is the mistake.

Step One: Protein — The Non-Negotiable

Protein is the most direct lever for lean mass preservation. There's no supplement that works if protein intake is inadequate. There's no training protocol that fully compensates for too little of it.

The clinical guidance for people on GLP-1 therapy is clear, if slightly variable depending on source: 1.2–2.0g of protein per kilogram of body weight per day. At the lower end, that's protection. At the upper end, it's optimization.

For a 170-pound (77kg) person, that's roughly 93–154g of protein daily. With appetite suppressed enough to reduce calorie intake by 30–40%, hitting that target from food alone is genuinely hard. Most people need to actively engineer it.

Practical strategies that work within a suppressed-appetite context:

  • Front-load protein at each meal. Eat the protein portion first, before appetite fades further into the meal. A chicken breast or Greek yogurt before anything else.
  • Use protein powder strategically. A 25–30g serving dissolved in something warm — coffee, broth, a small smoothie — is often more manageable than a full meal when nausea is a factor.
  • Prioritize leucine-rich sources. Leucine is the amino acid most directly linked to muscle protein synthesis. It's concentrated in whey, eggs, dairy, and meat. Plant-based sources work but typically require larger servings to deliver the same leucine load.

We reviewed the best protein powder options specifically for GLP-1 users — accounting for nausea, reduced appetite, and the whey vs plant protein question — in our GLP-1 protein powder guide.

Obesity

2024 · Controlled Study

People on tirzepatide who consumed 1.3g of protein per kg bodyweight per day preserved more lean mass than those eating less protein — in a 12-week trial.

The trial directly compared protein intakes within a tirzepatide-treated group, providing some of the most direct evidence available that protein intake modifies lean mass outcomes during GLP-1 therapy — not just theoretically, but in practice.

Read the full study in Obesity.

Step Two: Resistance Training — the Signal the Body Actually Listens To

Protein provides the raw material. Resistance training provides the signal to use it.

When you lift, you create micro-damage in muscle fibers. The body repairs that damage and builds the fibers slightly thicker and stronger — a process that requires protein and that signals to the body that this tissue is being used and needs to be preserved. In a caloric deficit, this signal is the primary reason the body holds onto muscle instead of burning it.

You don't need to be in a gym four days a week. Two to three sessions per week of compound resistance exercises — squats, deadlifts, rows, presses — covering the major muscle groups is enough to generate the signal that matters. Bodyweight training works. Resistance bands work. The principle is progressive overload: gradually increasing the challenge over time so the signal stays potent.

One thing worth naming explicitly: fatigue during GLP-1 dose escalation is real. Starting too aggressively is how people end up injured or burned out in month two. Starting at 60–70% of what feels hard and building from there is a better strategy than matching what you were doing pre-medication.

The research on GLP-1 therapy combined with exercise is unambiguous: people who exercise while on these drugs preserve more lean mass and lose more fat mass than people who rely on the medication alone.

Step Three: Creatine — The Supplement With the Most Evidence

If you're going to add one supplement specifically for muscle preservation during GLP-1 therapy, creatine monohydrate is it.

Creatine is the most-studied sports supplement in existence. It works by increasing phosphocreatine stores in muscle cells, which enhances the ATP regeneration that powers short-duration high-effort activity — which is exactly what resistance training is. More ATP availability means more output per session, which means a stronger training signal, which means better muscle preservation.

The dose is 5g per day. Timing doesn't matter much — consistency does. No loading phase is required, though some people use one to saturate stores faster.

One thing that trips people up: creatine pulls water into muscle cells, which typically adds 2–4 pounds on the scale in the first couple of weeks. This is intracellular hydration — it's not fat gain, and it's a sign the supplement is working. It can be psychologically jarring when you're on a GLP-1 and watching the scale closely.

↑LBM

Lean body mass

Obesity Pillars — 2025 Narrative Review

A 2025 narrative review in Obesity Pillars found that creatine supplementation combined with resistance training may preserve lean body mass during GLP-1 receptor agonist therapy. The review also noted that protein supplementation at 1.2–2.0g/kg/day was the foundational intervention, with creatine as a direct complement to resistance training.

Obesity Pillars, 2025 · Narrative review

What Else Helps — and What Doesn't

  • HMB (beta-hydroxy beta-methylbutyrate): A metabolite of leucine that's been studied for lean mass preservation in older adults and during caloric restriction. The evidence is less consistent than creatine, but in populations at high risk of muscle loss — women over 50 on GLP-1s especially — it may be worth adding at 3g per day. It's an adjunct, not a replacement for protein and training.
  • Collagen peptides: Useful for skin, hair, and joint support during rapid weight loss, but collagen is an incomplete protein — it lacks sufficient essential amino acids to drive muscle protein synthesis. It doesn't count toward your daily protein target for muscle preservation purposes.
  • BCAAs: Branched-chain amino acids have a vocal fanbase but limited standalone evidence when protein intake is already adequate. If you're hitting 1.2–2.0g/kg/day of total protein, BCAAs aren't adding much. If protein intake is lower, BCAAs are a bandage over a bigger problem.
  • Sleep: Not a supplement, but worth naming. Sleep is when the bulk of muscle repair happens. GLP-1 medications have shown benefit for sleep apnea in some trials, but general sleep quality can be disrupted during dose escalation. Prioritizing 7–9 hours and managing sleep hygiene matters for muscle preservation in a way that no supplement replicates.

The Muscle Loss — Weight Regain Connection

One reason to take lean mass preservation seriously from day one is what happens downstream if you don't.

SURMOUNT-4 showed that people who stopped tirzepatide after successful weight loss regained a meaningful portion of the weight — ending up around 10% below their original baseline rather than at their treatment nadir.

The biological driver of that regain is partly the return of appetite, but it's also metabolic: muscle tissue burns calories at rest. Less muscle means a lower resting metabolic rate, which means the same caloric intake that once maintained weight now produces regain.

In other words, the muscle you lose during treatment is the same muscle that would have helped you keep the weight off after treatment.

This is one of the reasons obesity medicine increasingly frames GLP-1 therapy as long-term — ideally indefinite — treatment rather than a course you complete. The discontinuation data supports that framing clearly. We covered the full picture in stopping a GLP-1 medication.

Putting It Together: The Day-One Protocol

Starting from the day your GLP-1 prescription begins — not after you've lost weight, not after you notice weakness:

  • Protein: Set a daily target of 1.2g per kilogram of body weight as a floor. Move toward 1.6g as appetite adjusts. Use protein powder to close the gap when food volume is limited.
  • Resistance training: Two sessions per week minimum. Three is better. Compound movements targeting major muscle groups. Start conservatively if fatigue is a factor during dose escalation.
  • Creatine: 5g per day, any time, with water. Consistent daily use matters more than timing. Expect a 2–4 pound temporary water weight bump in the first week or two — this is normal.
  • Multivitamin: Micronutrient depletion from eating less is real and compounds over months. A broad multivitamin is cheap insurance. We cover the full supplement stack, including top picks for GLP-1 users, in our GLP-1 supplement guide.

Editor's Note

Older adults and postmenopausal women are at meaningfully higher risk for lean mass loss on GLP-1 therapy — based on Endocrine Society data, age and sex are independent predictors of worse body composition outcomes on semaglutide. If you're in this group, the protein target should lean toward the upper end of the range (1.6–2.0g/kg), and resistance training is non-negotiable rather than optional.

For context on how this muscle loss pattern compares across semaglutide, tirzepatide, and the investigational retatrutide, our three-generation drug comparison covers the body composition data side by side.

For the complete supplement stack — not just creatine and protein, but every nutrient gap GLP-1 therapy creates — the GLP-1 supplement guide has the full protocol with product picks.

Talk to your prescriber or a registered dietitian about your specific protein targets and exercise tolerance before making major changes — particularly if you have kidney disease, as high protein intake requires clinical oversight in that population.

The Bottom Line

GLP-1s move the scale. Protein, training, and creatine determine how much of what moves is actually fat.

The 25–39% lean mass figure from clinical trials isn't inevitable — it's a baseline observed in people who weren't actively addressing it. The protocol isn't complicated: enough protein daily, resistance training twice a week, creatine every day. Those three things, started on day one and maintained consistently, change the body composition math in your favor.

Frequently Asked Questions

     Does Ozempic or Wegovy directly cause muscle loss?      +
     Not directly. The medication suppresses appetite, which creates a caloric deficit, which causes the body to draw on stored energy — including muscle protein. The lean mass loss is a consequence of the deficit and reduced protein intake, not a direct pharmacological effect of the drug. That distinction matters because it means it's addressable through diet and exercise rather than an unavoidable drug side effect.    
     How much protein do I need on a GLP-1 medication?      +
     Clinical guidance consistently points to 1.2–2.0g per kilogram of body weight per day during active weight loss on GLP-1 therapy. For a 160-pound (73kg) person, that's roughly 88–146g per day. Most people on these medications find it difficult to hit the target from food alone due to appetite suppression — a protein supplement is often the practical solution for closing the gap.    
     Will creatine make me gain weight on Ozempic?      +
     Creatine will cause 2–4 pounds of water weight to appear on the scale in the first one to two weeks. This is intracellular water being drawn into muscle cells — it's not fat gain and it doesn't represent real weight regain. Most people on GLP-1 medications continue to lose overall body weight even while creatine is building up. Think of that initial bump as the sign the supplement is doing its job.    
     Can I do resistance training while on Ozempic if I feel fatigued?      +
     Yes, but calibrate the intensity to how you're feeling — especially during dose escalation periods when fatigue tends to peak. Starting at 60–70% of your usual effort level and building from there is smarter than pushing through at full intensity and burning out. Two shorter sessions are more sustainable than one session that wrecks you for four days. The goal is consistency over weeks, not heroic single efforts.    
     Is muscle loss worse on tirzepatide than semaglutide?      +
     The available data suggests similar ratios — approximately 25% of total weight lost as lean mass for tirzepatide in SURMOUNT-1, with semaglutide data in a comparable range across most analyses. Some semaglutide studies in higher-risk populations (older women, lower protein intake groups) show lean mass percentages reaching 39%. The practical answer is that both drugs carry meaningful lean mass loss at scale, and the protocol for addressing it is the same for both.    

Editorial Disclaimer

This article is for informational purposes only and is not a substitute for professional medical advice. The Ritual Guide does not diagnose, treat, or cure any condition. Always consult your healthcare provider before starting any new supplement or exercise program, especially if you're pregnant, nursing, taking medication, or managing a chronic condition.

Share This Guide
The Ritualist

The weekly ritual for women who take their recovery as seriously as their ambition.

Science-backed, founder-curated. One email a week. No noise.

Subscribe to The Ritualist →
You’ll be taken to Substack to complete your signup.